| Dr Michael E Schoeffler, MD | |
|
4050 W Memorial Rd Fl 3, Oklahoma City, OK 73120-8382 | |
| (405) 608-3800 | |
| (405) 753-1870 |
| Full Name | Dr Michael E Schoeffler |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 28 Years |
| Location | 4050 W Memorial Rd Fl 3, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912994880 | NPI | - | NPPES |
| 100131640C | Medicaid | OK | |
| P00064061 | Other | OK | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 20310 (Oklahoma) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 20310 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Oklahoma Heart Hospital, Llc | Oklahoma city, OK | Hospital |
| Oklahoma Heart Hospital South, Llc | Oklahoma city, OK | Hospital |
| Holdenville General Hospital | Holdenville, OK | Hospital |
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohh Physicians Llc | 1759392079 | 122 |
News Archive
Alloiococcus otitidis can be a dominant bacterial pathogen among indigenous Australian children with acute otitis media with perforation, although its main role appears to be that of a secondary pathogen, preliminary study findings suggest.
Amgen today announced that it will present data from several Prolia (denosumab) studies, including eight year efficacy and safety data from a Phase 2 extension study in women with postmenopausal osteoporosis with low bone mineral density (BMD), at the 2011 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in San Diego, Calif. from Sept. 16-20, 2011.
Ukraine's Parliament recently approved a bill that would establish a national program to increase HIV/AIDS prevention and treatment efforts in the country, Ukrainian News reports.
Accuray Incorporated, the premier radiation oncology company, announced today the signing of a multi-year master research and collaboration agreement with the University of Heidelberg, a luminary research institution located in Heidelberg, Germany that contributes to the city's top international position in therapy, research and science.
› Verified 7 days ago
| Entity Name | Mercy Hospital Oklahoma City, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922192186 PECOS PAC ID: 8022920982 Enrollment ID: O20031110000161 |
News Archive
Alloiococcus otitidis can be a dominant bacterial pathogen among indigenous Australian children with acute otitis media with perforation, although its main role appears to be that of a secondary pathogen, preliminary study findings suggest.
Amgen today announced that it will present data from several Prolia (denosumab) studies, including eight year efficacy and safety data from a Phase 2 extension study in women with postmenopausal osteoporosis with low bone mineral density (BMD), at the 2011 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in San Diego, Calif. from Sept. 16-20, 2011.
Ukraine's Parliament recently approved a bill that would establish a national program to increase HIV/AIDS prevention and treatment efforts in the country, Ukrainian News reports.
Accuray Incorporated, the premier radiation oncology company, announced today the signing of a multi-year master research and collaboration agreement with the University of Heidelberg, a luminary research institution located in Heidelberg, Germany that contributes to the city's top international position in therapy, research and science.
› Verified 7 days ago
| Entity Name | Ohh Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023087772 PECOS PAC ID: 1759392079 Enrollment ID: O20060525000059 |
News Archive
Alloiococcus otitidis can be a dominant bacterial pathogen among indigenous Australian children with acute otitis media with perforation, although its main role appears to be that of a secondary pathogen, preliminary study findings suggest.
Amgen today announced that it will present data from several Prolia (denosumab) studies, including eight year efficacy and safety data from a Phase 2 extension study in women with postmenopausal osteoporosis with low bone mineral density (BMD), at the 2011 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in San Diego, Calif. from Sept. 16-20, 2011.
Ukraine's Parliament recently approved a bill that would establish a national program to increase HIV/AIDS prevention and treatment efforts in the country, Ukrainian News reports.
Accuray Incorporated, the premier radiation oncology company, announced today the signing of a multi-year master research and collaboration agreement with the University of Heidelberg, a luminary research institution located in Heidelberg, Germany that contributes to the city's top international position in therapy, research and science.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael E Schoeffler, MD 7800 Nw 85th Ter, Oklahoma City, OK 73132-3385 Ph: () - | Dr Michael E Schoeffler, MD 4050 W Memorial Rd Fl 3, Oklahoma City, OK 73120-8382 Ph: (405) 608-3800 |
News Archive
Alloiococcus otitidis can be a dominant bacterial pathogen among indigenous Australian children with acute otitis media with perforation, although its main role appears to be that of a secondary pathogen, preliminary study findings suggest.
Amgen today announced that it will present data from several Prolia (denosumab) studies, including eight year efficacy and safety data from a Phase 2 extension study in women with postmenopausal osteoporosis with low bone mineral density (BMD), at the 2011 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in San Diego, Calif. from Sept. 16-20, 2011.
Ukraine's Parliament recently approved a bill that would establish a national program to increase HIV/AIDS prevention and treatment efforts in the country, Ukrainian News reports.
Accuray Incorporated, the premier radiation oncology company, announced today the signing of a multi-year master research and collaboration agreement with the University of Heidelberg, a luminary research institution located in Heidelberg, Germany that contributes to the city's top international position in therapy, research and science.
› Verified 7 days ago
Evelyn Lorents, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |